Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
302 Leser
Artikel bewerten:
(2)

Rancho BioSciences, LLC: Rancho Biosciences Expands Leadership in Biomedical Ontology With Appointment of Dr. Jane Lomax

Industry-recognized expert SciBite, and Pistoia Alliance Board Member, joins Rancho to advance structured data solutions for life sciences innovation

SAN DIEGO, CA / ACCESS Newswire / September 17, 2025 / Rancho Biosciences, most trusted partner for scientific data services for the life sciences industry, today announced the appointment of Dr. Jane Lomax as Head of Terminology Services. A globally respected leader in the field of biomedical ontology, Dr. Lomax brings decades of experience guiding ontology strategy, development, and governance for high-impact initiatives across pharma, academia, and global data consortia.

Most recently, Dr. Lomax served as Head of Ontologies for SciBite at Elsevier, where she led the development of ontology-based tools to power semantic search, data integration, and AI-ready knowledge systems. She has also served on the Board of the Pistoia Alliance and is actively involved in several of its ontology projects. She is well known for her work on landmark projects such as the Gene Ontology (GO), International Society for Biocuration, and Open Biomedical Ontologies (OBO) Foundry.

"Ontologies are the foundation for making scientific data truly interoperable and ready for discovery," said Dr. Lomax. "Joining the Rancho team feels like becoming part of a shared mission with people who believe, as I do, in saving lives through data by making it work harder, reach more people, and accelerate discovery."

Marc Ginsky, CEO of Rancho Biosciences, said: "Jane is one of the most respected leaders in the biomedical ontology field, and her track record speaks for itself. With her expertise, Rancho is even better positioned to set the standard for intelligent, interoperable and analysis- ready biomedical data-and to deliver that value at scale for our clients worldwide."

Tatiana Khasanova, SVP Science & Technology, added: "Jane's arrival strengthens the deep scientific and technical foundation that Rancho has built over more than a decade. She brings not just extraordinary knowledge of ontologies, but also a collaborative mindset that will help our clients navigate the complexities of data harmonization and knowledge modeling with confidence."

The appointment comes as Rancho continues to expand its global impact in helping pharmaceutical, biotech, and research organization's structure and harmonize their data assets-accelerating drug discovery, translational research, and AI/ML development.

Dr. Lomax will also represent Rancho at the upcoming Pistoia Alliance Conference in Q4, where the company is a featured sponsor and speaker. Her presence further reinforces Rancho's role as a thought leader in advancing FAIR data principles and domain-driven data innovation in life sciences.

About Rancho Biosciences
Rancho Biosciences is a trusted scientific data partner to the life sciences industry, helping pharmaceutical, biotech, and research organizations transform complex biomedical data into high-quality, AI-ready assets. Our expertise spans strategic data consulting, ontology development, curation, harmonization, engineering, and advanced analytics across omics, clinical, imaging, and preclinical domains.

We combine scientific insight, data mastery, and engineering excellence to deliver solutions that are precise, scalable, and built for impact. Known for speed, rigor, and the ability to make the hard things in data seem easy, Rancho serves as the backbone behind breakthroughs-empowering clients to accelerate discovery, improve decision-making, and ultimately save lives through data.

Learn more at www.ranchobiosciences.com

Contact Information

Yigal Uriel
Digital Marketing Manager
yigal.uriel@ranchobiosciences.com

.

SOURCE: Rancho BioSciences, LLC



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/rancho-biosciences-expands-leadership-in-biomedical-ontology-with-app-1068974

© 2025 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.